New Stock Offerings - Fushun Special Steel (600399) is undergoing a tender offer period from August 12, 2025, to September 10, 2025[1] - *ST Tianmao (000627) has a cash option declaration period from September 15, 2025, to September 19, 2025[1] - Tianpu Co., Ltd. (605255) has announced its latest updates on September 4, 2025[1] Market Alerts - Kaipu Cloud (688228) has reported severe abnormal fluctuations as of August 30, 2025[1] - Siquan New Materials (301489) and Xinhua Jin (600735) also reported significant market movements on August 22 and August 30, 2025, respectively[1] - Multiple companies including *ST Baoying (002047) and Wantong Development (600246) have updates as of September 4, 2025[1] Trading Notifications - A total of 30 companies have issued trading notifications with specific dates for announcements and updates, indicating active market participation[1] - The report includes links to detailed announcements for each company, ensuring transparency and accessibility of information[1]

New Stock Offerings - Fushun Special Steel (600399) has a tender offer period from August 12, 2025, to September 10, 2025[1] - ST Tianmao (000627) has a cash option declaration period from September 15, 2025, to September 19, 2025[1] - Tianpu Co., Ltd. (605255) announced significant trading activity on September 3, 2025[1] Market Volatility - Kaipu Cloud (688228) reported severe abnormal fluctuations on August 30, 2025[1] - Xinhua Jin (600735) experienced significant trading activity on August 30, 2025[1] - ST Chuntian (600381) had notable trading activity on September 3, 2025[1] Other Notable Announcements - ST Er Ya (600107) reported trading activity on September 3, 2025[1] - Shanghai Electric Power (600021) had significant trading activity on September 3, 2025[1] - ST Gao Hong (000851) reported trading activity on September 3, 2025[1]

Group 1: 恒瑞医药 - Company received approval for clinical trials of HRS-7172 tablets, a new anti-tumor small molecule inhibitor [1] - Subsidiary received approval for SHR-A2009, an antibody-drug conjugate targeting HER3 [1] - Company was established in April 1997, focusing on drug research, production, and sales [1] Group 2: 康德莱 - Controlling shareholder plans to transfer 5% of shares to strategic investor at a price of 10.81 yuan per share, totaling 236 million yuan [1] - Post-transfer, controlling shareholder's stake will decrease from 39.58% to 34.58% [1] - Company was established in July 1998, specializing in medical devices [2] Group 3: 中钢洛耐 - Shareholder plans to reduce holdings by up to 1% of total shares due to fund exit needs [3] - Company was established in August 2006, focusing on high-end refractory materials [3] Group 4: 瑞玛精密 - Subsidiary completed acquisition of land in Mexico for production operations, covering 52,300 square meters at a price of 3.4064 million USD [4] - Company was established in March 2012, specializing in precision metal stamping and related products [4] Group 5: 鸿博股份 - Company confirmed normal operations despite stock price fluctuations exceeding 20% over three trading days [5] - Company was established in June 1999, focusing on lottery services and high-end packaging [6] Group 6: 东芯股份 - Company completed stock trading risk investigation and resumed trading [7] - Company was established in November 2014, specializing in storage chip design and sales [7] Group 7: 凯迪股份 - Company stated that its robot products are still in development and will not generate revenue in the short term [8] - Company was established in August 1992, focusing on linear drive systems [8] Group 8: 诺唯赞 - Major shareholder plans to reduce holdings by up to 3% due to funding needs [9] - Company was established in March 2012, focusing on functional proteins and organic materials [9] Group 9: 君实生物 - Company received approval for clinical trials of JT118 injection, a "two-in-one" recombinant protein vaccine for monkeypox [10] - Company was established in December 2012, focusing on new drug research and related services [10] Group 10: 赛力斯 - Company reported August sales of 45,818 vehicles, with a 19.57% increase in new energy vehicle sales [11] - Company was established in September 2012, focusing on automotive research and sales [11] Group 11: 燕东微 - Major shareholder plans to reduce holdings by up to 1% due to management needs [13] - Company was established in October 1987, focusing on semiconductor products and services [13] Group 12: 中百集团 - Company reported cumulative litigation and arbitration amounts of approximately 262 million yuan over the past 12 months [14] - Company was established in January 1990, focusing on retail business [14] Group 13: 金开新能 - Company received 939 million yuan in renewable energy subsidies, with a 341.67% increase year-on-year [15] - Company was established in March 1997, focusing on renewable energy development and operation [15] Group 14: *ST天茂 - Company plans to terminate stock listing and initiate cash option mechanism for shareholders [16] - Company was established in November 1993, focusing on various insurance services [16] Group 15: 宁德时代 - Company repurchased 8.69 million A-shares for a total of 2.131 billion yuan [17] - Company was established in December 2011, focusing on battery research and production [17] Group 16: 山西高速 - Controlling shareholder plans to increase holdings by 30 to 60 million yuan [18] - Company was established in February 1996, focusing on highway management [18] Group 17: 青岛银行 - Major shareholder plans to increase holdings by 233 to 291 million shares [19] - Company was established in November 1996, focusing on banking services [19] Group 18: 格力电器 - Major shareholder completed share increase of 46.38 million shares for 2.099 billion yuan [20] - Company was established in December 1989, focusing on air conditioning production and sales [20] Group 19: 中国石油 - Company plans to transfer 541 million A-shares to China Mobile Group to enhance strategic cooperation [21] - Company was established in November 1999, focusing on oil and gas exploration and production [21] Group 20: 镇洋发展 - Company announced a merger plan with Zhejiang Huhangyong Highway Co., with a share exchange ratio of 1:1.08 [22] - Company was established in December 2004, focusing on chemical products [22]

Core Viewpoint - Hongbo Co., Ltd. announced that its stock price experienced an abnormal fluctuation, with a cumulative decline of over 20% in closing prices over three consecutive trading days from August 29 to September 2, 2025 [2] Company Summary - The company conducted a self-examination and found no need to correct or supplement previously disclosed information [2] - No significant undisclosed information that could have impacted the stock trading price was identified in recent public media reports [2]

Group 1 - The company's stock price experienced abnormal fluctuations on August 29, 2025, as per the regulations of the Shenzhen Stock Exchange [1] - The company conducted a self-examination and confirmed that there are no undisclosed significant matters that could impact stock trading [1][3] - For the first half of 2025, the company reported a revenue of 790,126,927.40 yuan and a net profit attributable to shareholders of 42,259,139.29 yuan [1] Group 2 - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange rules [1] - The company has not identified any need to correct or supplement previously disclosed information [1]

Core Viewpoint - Hongbo Co., Ltd. (002229) announced that its stock price experienced an abnormal fluctuation, with a cumulative decline of over 20% in the closing prices on August 29, September 1, and September 2 [1] Company Situation - The company's current operating conditions are normal, and there have been no significant changes in the internal and external operating environment [1] - A self-examination and inquiry revealed that the company's directors, supervisors, and senior management did not engage in buying or selling the company's stock during the period of abnormal price fluctuation [1]

证券代码：002229 证券简称：鸿博股份 公告编号：2025-047 鸿博股份有限公司 关于股价异动的公告 1、公司前期披露的信息不存在需要更正、补充之处； 2、公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较 大影响的未公开重大信息； 3、公司目前经营情况正常，内外部经营环境未发生重大变化； 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况 鸿博股份有限公司（以下简称"公司"）股票交易价格于 2025 年 8 月 29 日、 9 月 1 日、9 月 2 日连续三个交易日收盘价格跌幅偏离值累计超过 20%，根据深 圳证券交易所相关规定，属于股票交易异常波动的情况。 二、公司关注并核实相关情况 针对公司股票异常波动，公司进行了自查，并对相关事项进行了核查，现将 有关情况说明如下： 4、经核查，除公司日常经营涉及事项外（包括业务洽谈、银行授信、对子 公司提供担保等），公司根据目前已确认的信息，不存在关于公司的应披露而未 披露的重大事项，也不存在处于筹划阶段的重大事项； 5、经自查和函询，公司董事、监事及高级管理人员在公司股 ...

Core Viewpoint - Hongbo Co., Ltd. (002229) reported significant growth in its 2025 mid-year financial results, with total revenue reaching 790 million yuan, a year-on-year increase of 197.92%, and a net profit of 42.26 million yuan, up 206.81% compared to the previous year [1] Financial Performance - Total revenue for the first half of 2025 was 790 million yuan, compared to 265 million yuan in the same period of 2024, reflecting a growth of 197.92% [1] - The net profit attributable to shareholders was 42.26 million yuan, a significant turnaround from a loss of 39.56 million yuan in 2024, marking a year-on-year increase of 206.81% [1] - The second quarter of 2025 saw total revenue of 113 million yuan, a slight increase of 2.69% year-on-year, but a net loss of 42.32 million yuan, a decline of 191.86% compared to the previous year [1] Profitability Metrics - The gross profit margin improved to 20.06%, with a year-on-year increase of 125.58%, while the net profit margin reached 6.1%, up 150.31% from the previous year [1] - The total of selling, administrative, and financial expenses was 69.32 million yuan, accounting for 8.77% of revenue, a decrease of 66.49% year-on-year [1] Asset and Liability Management - Cash and cash equivalents decreased to 431 million yuan, down 27.58% from the previous year [1] - Accounts receivable also declined to 237 million yuan, a decrease of 21.31% year-on-year [1] - Interest-bearing liabilities increased to 450 million yuan, reflecting a rise of 21.72% compared to the previous year [1] Shareholder Metrics - The net asset per share was 2.6 yuan, down 14.08% year-on-year, while earnings per share improved to 0.09 yuan, a significant increase of 206.86% [1] - Operating cash flow per share was -0.19 yuan, a decrease of 17.20% compared to the previous year [1] Historical Performance Insights - The company's historical financial performance has been mixed, with a median Return on Invested Capital (ROIC) of 1.01% over the past decade, indicating weak investment returns [1] - The worst year for ROIC was 2024, with a value of -12.72%, highlighting the company's fragile business model [1]

Core Points - The company held the 28th meeting of the 6th Supervisory Board on August 29, 2025, to review and approve various proposals [1][2] - The meeting concluded with unanimous approval of the 2025 semi-annual report and its summary, confirming compliance with relevant regulations [1][2] - The special report on the use of raised funds for the first half of 2025 was also approved, indicating no violations in the use of these funds [2] - A proposal to amend the company's articles of association was passed, which will be submitted for shareholder approval [2] Group 1 - The meeting was convened and chaired by Mr. Hu Wei, with all three supervisors present [1] - The semi-annual report was deemed true, accurate, and complete, with no misleading statements or omissions [1][2] - The special report on the use of raised funds accurately reflects the storage and actual use of funds, adhering to legal requirements [2] Group 2 - The proposal to amend the articles of association requires further review by the company's shareholders [2] - The specific contents of the semi-annual report and the special report can be found on designated information disclosure websites [2]

Meeting Overview - The company will hold its third extraordinary general meeting of shareholders on September 15, 2025, as approved in the board meeting on August 28, 2025 [1][2] - The meeting will be conducted both in-person and via online voting, with specific time slots for each [1][2] - The record date for shareholders to attend the meeting is September 9, 2025 [2] Voting Procedures - Shareholders can choose either in-person or online voting, with the first valid vote being the determining result [2] - The meeting will include both ordinary and cumulative voting proposals, with specific requirements for approval [3][4] - The company will separately count votes from small investors, defined as those not holding more than 5% of shares [4] Agenda Items - The meeting will review several proposals, including amendments to governance systems and the election of the seventh board of directors [2][4] - Proposals related to the election of independent and non-independent directors will require a two-thirds majority for approval [4] Registration Details - Registration for the meeting will occur on the day of the meeting, with specific time slots for attendees [5] - Attendees must provide identification and relevant documentation for registration [5] Online Voting Instructions - Shareholders can participate in online voting through the Shenzhen Stock Exchange's trading system and internet voting platform [6] - Detailed procedures for online voting are provided, including identity verification requirements [6]